SURVYR

MTD

Mettler-Toledo International Inc.
$1,685.32
+$15.70 (0.94%)Oct 27 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-28%-16%-4%+9%+21%Oct 2025Oct 2026Apr 202652w high $1,713.3952w low $1,023.05
MTDSPY
Wall St. Highest PT $1,700.00 (+0.9%) Wall St. Avg PT $1,525.67 (-9.5%)
$1,026$1,207$1,388$1,570$1,751POC $1,426Hi $1,700Avg $1,526
Underwater Drawdown %Max DD -31.9%Current 0.0%
0.0%-31.9%
Relative Strength vs SPY+5.2% vs SPYOutperforming
+42%0%-42%
1W
+$51.31 (3.14%)
1M
+$173.68 (11.49%)
3M
+$296.94 (21.39%)
6M
+$422.84 (33.49%)
YTD
+$291.13 (20.88%)
1Y
+$265.61 (18.71%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Hold
12 analysts · mean score 2.62
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$1,685.32
Average target$1,525.67
−$159.65 (−9.5%) downsideaverage target vs current price
CurrentAverageMedian
Low$1,200.00
Median$1,525.67
High$1,700.00
12-month Wall Street target range
Recent analyst rating changes · 30
Reiterated
2026-10-13 · Morgan Stanley reiterated Equal-Weight on MTD
Reiterated
2026-10-07 · Barclays reiterated Overweight on MTD
Initiated
2026-09-02 · Rothschild & Co started covering MTD at Sell
Initiated
2026-09-01 · RBC Capital started covering MTD at Sector Perform
Reiterated
2026-08-04 · Morgan Stanley reiterated Equal-Weight on MTD
Reiterated
2026-08-03 · Evercore ISI Group reiterated Outperform on MTD
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$33.5B
P/E (last 12 months)37.6
P/E (next 12 months, estimated)32.3
52-week range$1,023.05 – $1,713.39
Revenue growth (latest quarter vs a year ago)+4.5%
Dividend yieldNo dividend
Analyst consensusHold (12)
Average analyst price target$1,525.67 (-9%)

What they do

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters.

Healthcare · Diagnostics & Research
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
38th percentile in sector
C-
12-1 return: +6.7%
Percentile within its GICS sector across the S&P 1500.
Growth
24th percentile in sector
D
Revenue growth (YoY): +4.5%
Percentile within its GICS sector across the S&P 1500.
Value
17th percentile in sector
D
Forward E/P: 3.2% · EBITDA/EV: 3.7%
Percentile within its GICS sector across the S&P 1500.
Profitability
84th percentile in sector
A-
Profit margin: +21.9% · Return on equity: –
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
ranked 219 of 499 · 12-month momentum 14.5%
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

MTD earningsNext report in 8 days
Next report · quarter Sep 2026
Thu Nov 5, 2026After the close
EPS consensus$12.09 range $11.82–$12.28
Revenue consensus$1.1B 11 analysts
Last 4 quarters · EPS vs estimate
Jul 30, 2026$11.46est $10.80+6.1%Above estimates
May 7, 2026$8.91est $8.71+2.3%Above estimates
Feb 5, 2026$13.36est $12.81+4.3%Above estimates
Nov 6, 2025$11.15est $10.66+4.6%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-24 11:10:11 ET
24-1125-0225-0525-0725-1126-0226-0526-070.0013.36
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$1.0B+4.5%
2026-03-31$947.1M–
2025-12-31$1.1B–
2025-09-30$1.0B–
2025-06-30$983.2M–

News & catalysts

More news
3 Reasons MTD is risky and 1 stock to buy instead
StockStory · Oct 23
Rating changes
Reiterated
2026-10-13 · Morgan Stanley reiterated Equal-Weight on MTD
Reiterated
2026-10-07 · Barclays reiterated Overweight on MTD
Initiated
2026-09-02 · Rothschild & Co started covering MTD at Sell
Initiated
2026-09-01 · RBC Capital started covering MTD at Sector Perform
Reiterated
2026-08-04 · Morgan Stanley reiterated Equal-Weight on MTD
Reiterated
2026-08-03 · Evercore ISI Group reiterated Outperform on MTD

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
Kaltenbach Patrick
President and CEO · 2026-08-27
Sell
$1.3M
Salice Thomas P
Director · 2026-08-05
Sell
$600.7K
Vadala Shawn
Chief Financial Officer · 2026-08-03
Sell
$3.2M
Keller Gerry
Head of Process Analytics · 2026-08-03
Sell
$342.5K
Salice Thomas P
Director · 2026-08-03
Sell
$599.5K
None
None · None
Sell
–

Stats refreshed 2026-10-24 11:10:11 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026